Q3 FY26 results: consolidated PAT Rs 38 cr, revenue up 243% YoY
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.5 pts less than Nifty Microcap 250 and 5.3 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q3 FY26 unaudited results. Consolidated 9M revenue rose to Rs 210.85 cr from Rs 61.52 cr, up 243%. Consolidated 9M PAT at Rs 38.14 cr vs Rs 10.42 lakh loss. Standalone 9M loss of Rs 1.44 cr. Company Secretary Aravindkumar V resigns effective Feb 10. Malaysian subsidiary restructured with trustee holding 51%. Fine levied for delayed Related Party Transaction disclosure; Board pledges future compliance.
Strong consolidated profit turnaround, but standalone still in loss. Governance flag from Related Party Transaction fine levied by exchanges.